Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

CDiddy, Firs of all, this is a P2 trial. I t

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154959
(Total Views: 624)
Posted On: 03/05/2021 3:51:21 PM
Avatar
Posted By: TechGuru
Re: CDiddy #80869
CDiddy,

Firs of all, this is a P2 trial.

I think they are taking it step by step. We see if it works -> It does -> We design quickly a P3 with fine-tuned parameters -> We do a P3 with much enhanced possibility of success -> We get approved.

Now, if we blow it out of the water with P2 we request EUA for LH treatment.

We have 100M affected by COVID-19, 30% might be LH as per Dr. Osterholm interview this morning: "this is going to transform medical practice."

Most insidious effect is brain-fog.

CYDY will be a player here.

OK. Now to Power of trial, which is not that important in P2 but nevertheless ... why did they lower the number of patients ??

To finish it ASAP and go on to P3. There will not be shortage of patients !!!. This is a different ball game.

Now, let's get technical. Can we do a P2 with adequate power with 50 patients ??

Yes, provided we have a very high effectivity. In this kind of trials there is not a dichotomous results (like live and death). Here we have a continuous response, for example in a scale to 1 to 10. All the patients result in a number and all the numbers are made to conform to a probability distribution.

Then one can make analysis on p-values and/or Power.

So, what is important is the difference of the averages of the measurements between the SOC and VX, how much the measurements scatter around the mean (called standard deviation) and what kind of reduction is measured between the groups (reduction on the average/mean).

For example, lets assume we will measure the patients symptoms in a scale from 0 to 10 and, at the end of the trial we expect that SOC mean is 6 with 1.4 standard deviations scatter. Also, we expect a 20% improvement with VX (4.8 mean).

How many patients do we need for a power of 90% ?? We need 58 patients.

This is just an example, I have no idea of what assumptions CYDY made. For the sake of having some fun, let assume we are expecting 15% improvement (5.1) mean. We would need 102 patients.

So, not easy to know why 50 patients as we HAVE to make assumptions on SOC results, VX results and standard deviations (data scattering).

My point is: I believe we are trying to do a quick-and-dirty trial, get data and then launch a bona-fide P3. In the mean time ascertain if VX works spectacularly or not and apply for EUA if this is the case.

Let's get started !!!!




(13)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us